Identification of a Specific Pseudo attP Site for Phage phiC3 Integrase in the Genome of Chinese Hamster in CHO-K1 Cell Line

Document Type: Research Paper

Authors

1 Department of Animal Science, Ferdowsi University of Mashhad, Mashhad, IR Iran

2 Department of Molecular Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, ACECR, Isfahan, IR Iran

3 Department of Molecular Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, ACECR, Isfahan, IR Iran and Biology Department, School of Sciences, University of Isfahan, Isfahan, IR Iran

4 Department of Reproductive Biotechnology, Reproductive Biomedicine Center, Royan Institute for Biotechnology, Isfahan, IR Iran

Abstract

Background: PhiC31 integrase is a DNA site-specific recombinase integrates DNA into the chromosomes between the two sites of attB and attP. Several pseudo attPs have been identified in mammalian genomes with critical features for long-term expression of transgene. In this manuscript, we report a novel intrinsic pseudo attP site named CHOL1 in the Chinese hamster genome implementing an inverse Polymerase Chain Reaction (IPCR).
Objectives:Identification of pseudo attP site(s) of Tenecteplase cDNA integration in the genome of stable transformed CHO cell line.
Materials and Methods: First, genome was extracted from a stable transformed CHO cell line expressing Tenecteplase. By creating of minicircle DNA in the last step, sequenc‌ing was performed.
Results: We obtained one band. BLAST analysis of the respective sequence of inverse PCR band identified a pseudo attP site.
Conclusions: Data demonstrated that the phiC31 integrase provides a suitable insertion site in the genome to express the gene of interest.

Keywords


1. Background

Nowadays, recombinant proteins have been produced in basic and applied studies. Several systems have been introduced for the efficient production of recombinant proteins in a large scale. The simplest one is overexpres­sion of recombinant proteins in bacterial systems. How­ever, one of the main disadvantages is the requirement of proper folding environment or posttranslational modi­fication for accurate biological activity of recombinant proteins. In spite of this, using eukaryotic expression system could bypass this problem (1). To obtain robust and long-term expression in the eukaryotic systems, in­tegration of the gene of interest should be in appropri­ate location in the genome of target cell. However, most of current methods for stable integration of exogenous DNA into genome involve random integration of DNA (2, 3). In random integration, the expression of recombinant protein mainly depends on the positional effects of the adjacent sequences in target chromatin (4). Therefore, painstaking screenings are required to find best cellu­lar colonies for desired level of protein expression of the target gene. Recently, PhiC31 integrase, as a site specific recombinase, has been proven to minimize the random integration and provides a long-term expression with ef­ficient functionality in mammal cells (5, 6) PhiC31 inte­grase mediates recombination between two sequences of attB and attP. If an attB site is located at the exogenous plasmid carrying the gene of interest, phiC31 integrase would be capable of integrating whole sequence of the plasmid at similar native attP sites so called pseudo attP sites in the mammalian genome. This style of site specific integration leads to robust expression levels in the cell (7, 8). This feature minimizes position effects of nearby sequences around pseudo attP sites (9). In our previous study, we used this system for the long-term overexpres­sion of Tenecteplase protein in Chinese hamster ovary (CHO) cells (10).

2. Objectives

Since determination of integrated site in transgenic stable cell lines is essential, we tried to identify pseudo attP site in Chinese hamster genome using an inverse PCR (IPCR) in this paper.

3. Materials and Methods

Inverse PCR has been employed successfully for amplifi­cation of unknown regions of the genomic DNA, outside the boundaries of identified sequences (11, 12). This tech­nique involves digestion of genomic DNA with appropri­ate enzyme(s) (Figure 1A), creation of mini-circle DNA using self-ligation and appropriate primers to amplify known sequences at both sides of a DNA core region (12).

3.1. Cell Line

Tenecteplase producing CHO cell line (CHO+) was used in this study as was previously described (10).

3.2. Culture of CHO Cells and Genomic DNA Extraction

CHO+ and untransfected CHO cells (CHO-) were cul­tivated in Dulbecco’s Modified Eagle’s Medium/Ham’s Nutrient Mixture F-12 (Sigma) supplemented with 10% fetal bovine serum (Gibco) and 10% CO2 at 37°C in a hu­mid atmosphere. After 24 hours, CHO+ cells were treated with G418 (600 μg/mL, Sigma) and cultured for 3 days. Approximately 5×106 cells from each group (CHO+ and CHO-) were harvested and genomic DNA was extracted using DNeasy Blood and Tissue Kit (Qiagen) (Figure 1B). Restriction enzymes digestion and ligation were per­formed as follows: Five μg genomic DNA of each sample was digested with a pair of restriction enzymes, NheI and XbaI (Fermentas) (Figure 1C). For self-circularization of di­gested DNA in an inverse PCR (IPCR), low amounts of DNA (1, 2, 3 ng/μL-1) were used in 10 μL of the ligation reaction (TaKaRa) (Figure 1D).

3.3. PCR and Nested PCR

To detect site specific integration before starting nested PCR, a normal PCR was performed. In case of random exogenous plasmid integration in Chinese hamster ge­nome, intact attB arm should be amplified using attR and attB-F3 primers. Otherwise site specific integration causes breakage. Sequences of the primers are listed in Table 1. The PCR program used for amplification was as follow: 94°C for 5 min, followed by 35 cycles of 94°C for 30 sec, 56°C for 30 sec, and 72°C for 45 sec and a final exten­sion period of 72°C for 10 min. Then PCR products were subjected to 1% agarose gel (CinnaGen) in TBE buffer (90 mM Tris-HCl, 64.6 mM boric acid, 2.5 mM EDTA, pH 8.3). Nested PCR was performed for amplifying unknown regions of DNA. Five μL of ligation mixture was diluted with 15 μL dH2O, which was used as a template in the first round of PCR (PCRI) using TNK103-F and attB-F3 prim­ers. In the second round of PCR, 1 μL of PCRI product was used as template using USP296-9F and attB-F3 primers (10, 13). The PCR program was as follows: 94°C for 10 min, followed by 35cycles of 94°C for 45 s, 56°C for 45 sec, and 72°C for 4 min and a final extension period of 72°C for 10 min. Cloning and sequencing were performed as follows: One product band was obtained from IPCR. This band was purified and ligated into a T-vector (InsTAcloneTM PCR Cloning Kit, Thermo Scientific) and was sequenced. Sequence analysis was performed by BLAST with RefSeq­Gene sequence databases. We have already published the isolation and characterization of a stable transformant CHO cells producing Tenecteplase using phiC31 integrase (10). To evaluate site specific recombination with phiC31 integrase, a normal PCR was designed based on the break­age of attB arms in exogenous plasmid encompassing Te­necteplase CDS, as a positive control (Figure 2A, Lane 1).

4. Results

Polymerase chain reaction on CHO+ genome illustrated that attB arm was ruptured with the phiC31 integrase and the specific primers for this fragment did not amplify the expected size, (Figure 2A, Lane 3) confirming the site specific recombination occurred by phiC31 integrase in CHO+ cells. Thus, we tried to determine the pseudo attP site in the genome of CHO+ cells with an inverse PCR. First, compatible cohesive site producing restriction en­zymes was used (Figure 1A and Figure C). These enzymes cut the plasmid at least in one position. Thereby, the right site of the recombination could be amplified in nested PCR (Figure 1A). After creating self-minicircle DNA in the last step of inverse PCR, we obtained one band (Figure 2A, Lane 4). BLAST analysis of the inverse PCR band sequence showed that the junctions at the site of specific recombi­nation contained half of the attB site fused with the ge­nomic sequence of Chinese hamster (GenBank accession number: NW_003613759.1).

5. Discussion

We assigned the term of CHOL1 to this newly recog­nized pseudo attP site (Figure 2B). It has been proven that phiC31 enzyme can integrate a donor plasmid into the mammalian genome (6). Several studies have indicated that phiC31 integrase prefers identified sites that are named pseudo attP in several species including human (6, 14-17). Integration into these sites results in long-term expression of transgene in host cells (5, 6). Therefore, these sites could be assigned as a marker of site specific recombination in phiC31 integrase system. This system is feasible to produce desired proteins in CHO cells (7). In this study we tried to identify a pseudo attP site in Chi­nese hamster genome using inverse PCR named CHOL1. BLAST analysis indicated that CHOL1 sequence was simi­lar to WT attP sequence reported in previous studies (18). The most identical sequence was observed in core region of the attB (TTGA) which is critical for phiC31 integrase site specific recombination (Figure 2B). This site has a ho­mology (77%) with mouse genome sequence in chromo­some 10 (NC_000076.5).

Acknowledgements

This study was funded with a grant from the Royan In­stitute in support of M.H. Sekhavati to obtain his Ph.D. degree from the Ferdowsi University of Mashhad. The au­thors would like to express their gratitude to the Royan Institute for their full supports.

Authors’ Contribution

Mohammad Hadi Sekhavati: Conception and design, collection and/or assembly of data, data analysis and in­terpretation, manuscript writing. Kianoush Dormiani: Conception and design, data analysis and interpretation. Kamran Ghaedi: Conception and design, data analysis and interpretation, manuscript writing, final approval of manuscript. Yahaya Khazaie: Conception and design, data analysis and interpretation. Morteza Hosseini: Con­ception and design, data analysis and interpretation. Mo­jtaba Tahmoorespur: Data analysis and interpretation. Mohammad Reza Nasiri: Data analysis and interpreta­tion. Mahboubeh Foruzanfar: Technical assistance. Mo­hammad Hossein Nasr Esfahani: Conception and design, data analysis and interpretation, manuscript writing, fi­nal approval of manuscript.

Financial Disclosure

None of the authors has any conflicts of interest to dis­close and all authors support submission to this journal.

Funding/Support

The authors would like to express their gratitude to the Royan Institute for their full supports.

1.      Weikert S, Papac D, Briggs J, Cowfer D, Tom S, Gawlitzek M, et al. Engineering Chinese hamster ovary cells to maximize si­alic acid content of recombinant glycoproteins. Nat Biotechnol. 1999;17(11):1116-21.

2.      Lucas BK, Giere LM, DeMarco RA, Shen A, Chisholm V, Crowley CW. High-level production of recombinant proteins in CHO cells us­ing a dicistronic DHFR intron expression vector. Nucleic Acids Res. 1996;24(9):1774-9.

3.      Kaufman RJ. Overview of vector design for mammalian gene ex­pression. Mol Biotechnol. 2000;16(2):151-60.

4.      Kalos M, Fournier RE. Position-independent transgene expres­sion mediated by boundary elements from the apolipoprotein B chromatin domain. Mol Cell Biol. 1995;15(1):198-207.

5.      Groth AC, Olivares EC, Thyagarajan B, Calos MP. A phage integrase directs efficient site-specific integration in human cells. Proc Natl Acad Sci U S A. 2000;97(11):5995-6000.

6.      Thyagarajan B, Olivares EC, Hollis RP, Ginsburg DS, Calos MP. Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase. Mol Cell Biol. 2001;21(12):3926-34.

7.      Thyagarajan B, Calos MP. Site-specific integration for high-level protein production in mammalian cells. Methods Mol Biol. 2005;308:99-106.

8.      Ortiz-Urda S, Thyagarajan B, Keene DR, Lin Q, Calos MP, Khavari PA. PhiC31 integrase-mediated nonviral genetic correction of junctional epidermolysis bullosa. Hum Gene Ther. 2003;14(9):923-8.

9.      Karow M, Calos MP. The therapeutic potential of PhiC31 integrase as a gene therapy system. Expert Opin Biol Ther. 2011;11(10):1287-96.

10.   Dormiani K, Khazaie Y, Forouzanfar M, Ghaedi K, Mofid MR, Karbalaie K, et al. Creation of Tenecteplase Producing CHO Cell Line Using Site Specific Integrase From φC31 phage. Cell J. 2010;12(2):208-14.

11.   Ochman H, Gerber AS, Hartl DL. Genetic applications of an in­verse polymerase chain reaction. Genetics. 1988;120(3):621-3.

12.   Triglia T, Peterson MG, Kemp DJ. A procedure for in vitro am­plification of DNA segments that lie outside the boundaries of known sequences. Nucleic Acids Res. 1988;16(16):8186.

13.   Ou HL, Huang Y, Qu LJ, Xu M, Yan JB, Ren ZR, et al. A phiC31 in­tegrase-mediated integration hotspot in favor of transgene ex­pression exists in the bovine genome. FEBS J. 2009;276(1):155-63.

14.   Ma QW, Sheng HQ, Yan JB, Cheng S, Huang Y, Chen-Tsai Y, et al. Identification of pseudo attP sites for phage phiC31 integrase in bovine genome. Biochem Biophys Res Commun. 2006;345(3):984-8.

15.   Chalberg TW, Genise HL, Vollrath D, Calos MP. phiC31 integrase confers genomic integration and long-term transgene expres­sion in rat retina. Invest Ophthalmol Vis Sci. 2005;46(6):2140-6.

16.   Groth AC, Fish M, Nusse R, Calos MP. Construction of transgen­ic Drosophila by using the site-specific integrase from phage phiC31. Genetics. 2004;166(4):1775-82.

17.   Ortiz-Urda S, Thyagarajan B, Keene DR, Lin Q, Fang M, Calos MP, et al. Stable nonviral genetic correction of inherited human skin disease. Nat Med. 2002;8(10):1166-70.

18.   Olivares EC, Hollis RP, Chalberg TW, Meuse L, Kay MA, Calos MP. Site-specific genomic integration produces therapeutic Factor IX levels in mice. Nat Biotechnol. 2002;20(11):1124-8.